Funds and ETFs Thermo Fisher Scientific

Equities

TMO

US8835561023

Advanced Medical Equipment & Technology

Market Closed - Nyse 04:00:01 2024-06-14 pm EDT 5-day change 1st Jan Change
572 USD -0.03% Intraday chart for Thermo Fisher Scientific -1.56% +7.77%

ETFs positioned on Thermo Fisher Scientific

Name Weight AuM 1st Jan change Investor Rating
0.38% 1,166 M€ +0.26% -
0.38% 607 M€ +0.05% -
0.37% 560 M€ +10.19% -
0.36% 10 M€ +10.89%
0.35% 322 M€ +13.88% -
0.35% 29 M€ -.--% -
0.33% 252 M€ +7.61%
0.32% 26 M€ +16.85% -
0.31% 0 M€ 0.00% -
0.30% 414 M€ +11.31% -
0.30% 36 M€ +9.69% -
0.25% 1 M€ -.--% -
0.22% 324 M€ +7.90% -
0.22% 40 M€ +6.61% -
0.22% 9 M€ +9.76% -
0.19% 15 M€ -1.62% -
0.18% 13 M€ +21.29% -
0.18% 18 M€ +5.20% -
0.17% 114 M€ +4.32% -
0.15% 104 M€ +5.25% -
0.14% 17 M€ +3.32% -
Thermo Fisher Scientific Inc. specializes in the design, manufacturing and marketing of laboratory and scientific equipments. Net sales (including intragroup) break down by family of products as follows: - laboratory equipments (70%). Moreover, the group proposes chemical products (reagents, solvent, salts, etc.), consumable products (tubes, funnels, vials, etc.), as well as conditioning, warehousing, storage, etc.; - diagnostics equipment and products (15.3%); - scientific analysis equipments (14.7%): analyzer (of water, gas, grounds, etc.), mass spectrometers, molecular spectroscopes, microscopes, manometers, samplers, microbiology equipments, reactive agents, etc. Net sales break down by source of income into products sales (78.5%) and services (21.5%). Net sales break down geographically as follows: North America (53%), Europe (25.7%), Asia-Pacific (18.1%) and others (3.2%).
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
26
Last Close Price
572 USD
Average target price
629.5 USD
Spread / Average Target
+10.04%
Consensus
  1. Stock Market
  2. Equities
  3. TMO Stock
  4. Funds and ETFs Thermo Fisher Scientific